Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study Goshi NishimuraDaisuke SanoNobuhiko Oridate Original Article 21 July 2021 Pages: 1995 - 2003
Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study Byoung Hyuck KimMoon-June ChoJeanny Kwon Original Article 10 August 2021 Pages: 2004 - 2016
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer Hiroya TaniguchiToshiki MasuishiTakayuki Yoshino Original Article Open access 21 July 2021 Pages: 2017 - 2024
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer Hiroyuki OkuyamaYoshinori KagawaAkihito Tsuji Original Article 02 September 2021 Pages: 2025 - 2028
Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer Yukiharu HiyoshiToshiki MukaiYosuke Fukunaga Original Article 28 July 2021 Pages: 2029 - 2036
Preoperative iron status is a prognosis factor for stage II and III colorectal cancer Hiroshi SawayamaYuji MiyamotoHideo Baba Original Article 23 July 2021 Pages: 2037 - 2045
Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer Mitsuyoshi TeiShingo NouraHidetoshi Eguchi Original Article 27 July 2021 Pages: 2046 - 2052
EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma Jia WangYanlin ZhongGuixia Meng Original Article 21 July 2021 Pages: 2053 - 2064
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer Mitsuhito SasakiHideki UenoTakuji Okusaka Original Article Open access 08 August 2021 Pages: 2065 - 2072
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma Motohide UemuraNoboru NakaigawaToyonori Tsuzuki Original Article Open access 21 July 2021 Pages: 2073 - 2084
Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma Motohide UemuraNoboru NakaigawaToyonori Tsuzuki Correction Open access 27 August 2021 Pages: 2085 - 2086
Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab Zine‐Eddine KheneRomain KokorianKarim Bensalah Original Article 02 August 2021 Pages: 2087 - 2093
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer Yuto BabaEiji KikuchiMototsugu Oya Original Article 06 August 2021 Pages: 2094 - 2103
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy Kota IidaMakito MiyakeKiyohide Fujimoto Original Article 27 July 2021 Pages: 2104 - 2112
Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up Rihito AizawaKiyonao NakamuraTakashi Mizowaki Original Article 02 August 2021 Pages: 2113 - 2122
The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer Masayuki SekineTakayuki EnomotoDaisuke Aoki Original Article Open access 26 July 2021 Pages: 2123 - 2129
Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer Masayuki SekineTakayuki EnomotoDaisuke Aoki Correction Open access 09 September 2021 Pages: 2130 - 2130
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia Naoko HosonoHisayuki YokoyamaTomoki Naoe Original Article Open access 07 August 2021 Pages: 2131 - 2141
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse Hiroshi YasuiMasayuki KobayashiYoichi Imai Original Article 14 July 2021 Pages: 2142 - 2150
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma Dennis StrassmannBennet HensenPhilipp Ivanyi Original Article Open access 27 July 2021 Pages: 2151 - 2160